CooperVision Biofinity Contact Lenses Now Available in Extended Minus Power Range
Biofinity is manufactured from comfilcon A material. The water content of Biofinity is 48 percent, Dk is 128, and Dk/t is 160. The lens base curve is 8.6mm; diameter 14.0mm. It is now available in sphere power ranges of -0.25D to -6.00D in 0.25D steps and -6.00D to -10.00D in 0.50D steps.
ARBO Plans New Standards for Commercial Support of COPE Approved CE
According to the information provide by ARBO, the new standards are intended to benefit the relationship between industry and optometric continuing education and give clear direction to both providers and industry. By ensuring compliance with these standards, industry is protected, optometric CE integrity is protected and the profession benefits from subsidized education. In addition, the public is protected and benefits from improved quality of care.
There will be a period for appropriate comment and suggestion from stakeholders in the CE system. Final guidelines will be released during the AOA Congress in June with formal implementation likely on January 1, 2009.
ARBO President Christina Sorenson, O.D., stated, "Our commitment is to continue to provide salient and unbiased CE that is not influenced by a specific company, product or brand. Our responsibility is to provide and implement the standards necessary for establishing and protecting the integrity of optometric CE."
For further information, contact ARBO at 314-785-6000 or email arbo@arbo.org.
Hydrogel Vision Expands Toric Product Line
According to the company, Extreme H2O 54% Toric MC is designed for the 30% of astigmatic patients from 1.25D to 1.75D. The lens is available in 10°
Free diagnostic sets of the Extreme H2O 54% Toric LC and MC lenses are available directly through Hydrogel Vision and through any of their authorized Extreme H2O distributors. For more information, call 1-877-336-2482 or visit www.extreme-h2o.com.
CIBA Vision Introduces New Corporate Identity Including New Logo and Purpose Statement
CIBA Vision will phase in the new logo on product packaging and other materials throughout 2008, with full transition to the new logo on its product line expected by the end of 2009.
Increased Comfort Delivers Lasting Patient Satisfaction
More About ACUVUE® OASYS™
Important Safety Information
--ADVERTISING
B&L Researchers Awarded Scientific Honor from China's Shandong Institute of Pharmaceutical Research
Bausch & Lomb Freda, the company's pharmaceutical joint venture in the region, has recently relocated its research and development activities to the Institute's new facility, located in Jinan, China.
Johnson & Johnson Vision Care Announces Sponsorship of the USSF and Acuvue The Difference Is Real Trip to Beijing Sweepstakes
Per the company, through the USSF sponsorship, Johnson & Johnson Vision Care will educate athletes and fans about the important role vision plays in sports performance. The outreach will also extend beyond sports by showing the benefits of better vision in other aspects of daily life. The company also stated that U.S. Women's National Team member Heather O'Reilly will play a leading role in the efforts to educate athletes and other performance-minded individuals by sharing her personal story about the valuable role of vision in life.
The company also announced the launch of the Acuvue The Difference Is Real Trip to Beijing sweepstakes. The sweepstakes runs March 19 through April 11, 2008, and will provide four winners and their guests a once-in-a-lifetime chance to attend the Beijing 2008 Olympic Games.
According to the company, the sweepstakes is the centerpiece of a multifaceted campaign that explores the ways vision and eye health affects performance. With the help of Heather O'Reilly and Graham Erickson, O.D. and co-author of Sports Vision: Vision Care for the Enhancement of Sports Performance, the campaign also aims to educate Americans about how proper vision correction can help improve performance in other areas such as driving, work or academics.
For more details and the official rules for the sweepstakes, visit www.myspace.com/heathervision.
Abstract: IgE Antibody on Silicone Hydrogel Contact Lenses from Patients with CLPC
Worn contact lenses were collected and soaked in phosphate-buffered saline. The levels of eluted IgE and IgE retained on contact lenses were detected by enzyme-linked immunosorbent assay. IgE was detected in 6 of 12 cases of general CLPC, 8 of 21 cases of local CLPC, and none of 14 control contact lenses. The average level of eluted IgE was 0.54 +/- 1.06 IU/contact lens, 0.28 +/- 0.54 IU/contact lens, and 0.04 +/- 0.06 IU/contact lens for general CLPC, local CLPC, and the control group, respectively. The incidences of positive IgE were significantly higher in patients with CLPC (general and local) than in control subjects, but no statistical difference was found between general and local CLPC. Generally higher amounts of retained IgE were detected on contact lenses that had increased levels of eluted IgE. Contact lenses that were collected before or after a CLPC event did not show increased levels of IgE.
The authors concluded that the level of IgE is increased in the eyes of some patients during an acute event of CLPC. The similar incidence of IgE-positive cases and levels of IgE from general and local CLPC contact lenses suggest that the conditions may share similar causal pathways.
Zhao Z, Fu H, Skotnitsky CC, Sankaridurg PR, Willcox MD. IgE Antibody on Worn Highly Oxygen-Permeable Silicone Hydrogel Contact Lenses From Patients With Contact Lens-Induced Papillary Conjunctivitis (CLPC). Eye Contact Lens. 2008 Mar;34(2):117-21.
Editor's Commentary: Be Proactive
Carla Mack, O.D., F.A.A.O.
This month at www.siliconehydrogels.org: research on patient compliance, piggyback lenses for patients with irregular corneas, measuring intraocular pressure over higher modulus lenses, and part 1 of our 2007 AAO update.